Two cell-based gene therapies will address the debilitating hereditary blood disorder. The U.S. Food and Drug Administration (FDA) has granted approval of two groundbreaking cell-based gene therapies, Casgevy…
Read MoreMedication
FTC Sues to Block Acquisition of Exclusive Drug License
The deal would give the French company a pharmaceutical monopoly over Pompe Disease therapy. The Federal Trade Commission (FTC) has taken action to prevent Sanofi from acquiring an…
Read More
FDA Approves Tyruko for Multiple Sclerosis and Crohn’s Disease Treatment
Medication offers options to those who have relapsing forms of the disease. The U.S. Food and Drug Administration (FDA) has authorized Tyruko (natalizumab-sztn), the first biosimilar to Tysabri…
Read More